The Deadly Oversight in Women’s Heart Health
Ladies, it’s time for some straight talk about your heart.
If you think cardiovascular disease is just a man’s problem, think again. Heart disease is the number one killer of women, claiming more lives each year than all cancers combined.
But here’s the kicker—despite this staggering toll, women’s heart disease is chronically under-diagnosed and under-treated. And a big part of the problem lies in the very tools doctors use to assess risk.
The Framingham Risk Score (FRS), the gold standard for predicting heart attack and stroke risk, has a fatal flaw: it doesn’t account for the unique factors that put women’s hearts in danger.
But a groundbreaking new study is calling for a long-overdue upgrade to this outdated system…
The FRS looks at six key factors—age, gender, diabetes, cholesterol, smoking, and blood pressure—to estimate a person’s odds of a cardiovascular event in the next decade.
Seems comprehensive, right?
But as researchers from the Stanford University Living Matter Lab point out, the “gender” component is a mere checkbox, failing to capture the complex web of female-specific risk factors that can make or break heart health.
“Anatomically, female and male hearts are different,” the authors write. “Female hearts are smaller and have thinner walls. Yet, the diagnostic criteria for certain heart diseases are the same for women and men, meaning that women’s hearts must increase disproportionally more than men’s before the same risk criteria are met.”
In other words, by the time a woman’s heart sets off the FRS alarm bells, it may already be in crisis mode.
So what’s falling through the cracks? For starters, the hormonal rollercoaster of menopause.
“Estrogen protects your heart,” explains Dr. Evelina Grayver, director of Women’s Heart Health at Northwell Health. “But estrogen levels drop significantly during menopause, and research has already determined that this takes a toll on the heart.”
As estrogen dwindles, women face a higher risk of diabetes, obesity, high cholesterol, and heart disease—yet not a single risk calculator takes this into account.
Pregnancy complications, like preeclampsia and gestational diabetes, also wave red flags for future heart trouble, but they’re routinely overlooked in cardiology.
Even something as seemingly unrelated as breast calcification on a mammogram can hint at cardiovascular risk, but this crucial data point rarely makes it into the heart health conversation.
To fix these glaring blind spots, the Stanford researchers are calling for a data-driven overhaul of the FRS.
By leveraging large datasets and machine learning, they believe we can create a risk scoring system that finally captures the full spectrum of women’s heart health concerns.
But updating the algorithm is just the first step. We also need to tackle the pervasive problem of medical misogyny and the dismissal of women’s symptoms.
This bias means women often delay seeking help and face skepticism from healthcare providers when they do. The result? Delayed diagnoses, missed opportunities for early intervention, and tragically preventable deaths.
Fixing the FRS isn’t just about fairness—it’s about saving lives. By creating a risk assessment tool that truly sees women’s hearts, we can catch problems earlier, intervene more effectively, and give every woman the best shot at a long, healthy life.
To updating the algorithm,
Rachel Mace
Managing Editorial Director, e-Alert
with contributions from the research team
P.S. Is this “heart health” vitamin backfiring? Here’s what you need to know.
Sources:
